CCND2 and B-cell chronic lymphocytic leukemia: Finally, the tumor suppressor function of this cluster in CLL was demonstrated by the increased development of B-cell malignancies in the miR-15b/16-2 knockout mouse (45), which is in line with the control by miR15b/16-2 of the CCND2 (Cyclin D2), CCND1 and IGF1R (insulin-like growth factor 1 receptor) genes involved in proliferation and antiapoptotic pathways in mouse B cells.